NCT07158177View on ClinicalTrials.gov

Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

October 15, 2026

Study Completion Date

October 15, 2026

Conditions
Cataract and IOL Surgery
Interventions
DEVICE

Acrysof™ PanOptix™ toric or not, trifocal IOL CE marked, Alcon company.

both of the patient's eyes will be implanted: 1 CPO and the other APO

DEVICE

Clareon Panoptix

both of the patient's eyes will be implanted: 1 CPO and the other APO

Trial Locations (1)

75014

Assistance Publique - Hôpitaux de Paris, Ophtalomopôle - Hôpital COCHIN, Paris

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER